COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 – ES23

Literature search elucidated no references that were suitable for review. Evidence suggests NSAIDs can reduce acute inflammatory symptoms, but they may have no effect on, or worsen long term outcomes by masking worsening of acute respiratory tract infection.

Source:

National Institute for Health and Care Excellence